The Eureka Clinical AI platform from ConcertAI’s TeraRecon provides clinicians with the state-of-the-art artificial intelligence and deep learning technologies to deliver next-level CT and MR imaging through Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion software.
Brain perfusion scans measure blood flow in the brain and are used to provide critically needed information on the extent of tissue damage, for instance, due to acute ischemic stroke.1 Quickly mapping brain perfusion deficits is pivotal to minimize tissue damage in acute stroke management, and Cercare further enriches the workflow with layers of AI to produce volumetric measures, which directly impact clinical decision-making.2
“We are thrilled to join forces with another revolutionary technology company like Cercare,” said Dan McSweeney, President of TeraRecon. “This partnership illustrates our continued commitment to work with leading, like-minded, innovative companies to enable quick access to important patient data and ultimately improve clinical impact.”
“TeraRecon and Cercare Medical share the commitment to support clinical decision-making to enable the best possible patient care,” said Kim Beuschau Mouridsen, CEO of Cercare Medical. “We are pleased to enter into this global partnership to increase access to the latest perfusion technology, which is designed to easily integrate into existing workflows and provide healthcare professionals with deep, fast, and reliable patient insights.”
Cercare provides unique maps illustrating oxygen availability, in addition to blood flow and volume. This allows for a more detailed assessment of tissue pathology and therefore optimized patient management for a variety of use cases, including oncology, Alzheimer’s disease, and neoplasia.
Eureka Clinical AI is the leading AI SaaS imaging interpretation and clinical decision augmentation solution from ConcertAI’s TeraRecon. As the industry’s most broadly deployed platform, it is unique in that it is open to third-party AI algorithms, allowing consolidated management of all AI interpretation solutions with seamless PACS integrations. Multi-specialty care teams can see results and receive mobile alerts to confirm AI findings, ensuring optimal and timely patient interventions, management, and coordinated care delivery.
